A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study)

Authors:

Abstract
No abstract available
Funding Information
  • GlaxoSmithKline

This publication has 28 references indexed in Scilit: